Article
Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine.
Vaccine - 21 Jun 2007
Gruener Norbert H, Gerlach Tilman J, Ulsenheimer Axel, Diepolder Helmut M, Wierenga Eddy, Zachoval Reinhart, Heeg Malte, Pape Gerd Rudolf, Jung Maria-Christina
Abstract excerpt
BACKGROUND/AIMS: In hepatitis B virus infection, viral elimination is dependent on an efficient antiviral T cell response which is not detectable in chronic hepatitis B. Therefore, new therapeutic concepts focus on T cell activation, such as epitope-based T cell-targeted vaccines. However, with the development of peptide-based vaccines in mind, viral mutations frequently described in hepatitis B within known...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
